基于AIF-1炎症信号通路研究醛固酮诱导慢性肾脏病相关血管钙化机制

基本信息
批准号:81870503
项目类别:面上项目
资助金额:53.00
负责人:郝丽荣
学科分类:
依托单位:哈尔滨医科大学
批准年份:2018
结题年份:2022
起止时间:2019-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:郝建兵,张蕾,李纳琦,马吉芳,苑雪莹,张淑宇,李鑫,李煜姝
关键词:
哺乳动物雷帕霉素靶蛋白复合物1醛固酮慢性肾脏病血管钙化AIF1
结项摘要

Although increasing evidences show that aldosterone receptor antagonist can obviously inhibit chronic kidney disease (CKD) related vascular calcification, it is strictly limited in CKD patients due to the side effects of hyperkalemia. It is very important to explore the mechanism of aldosterone-induced vascular calcification. In the prophase research of relationship between aldosterone/AIF-1 and renal interstitial fibrosis, applicants proved that aldosterone exerts effect with a AIF-1-dependent pathway. Based on the effect of aldosterone in vascular calcification, applicants speculate aldosterone promote vascular calcification with a AIF-1-dependent pathway. However, whether AIF-1 is associated with vascular calcification is still unclear. Therefore, applicants put forward aldosterone induces vascular calcification by AIF-1 signal pathways, and attempt to demonstrate that aldosterone could activate AIF-1/NF-κB and AIF-1/mTORC1 signals, inducing the interactions of mononuclear macrophages, endothelial cells and vascular smooth muscle cells, promoting vascular smooth muscle cells inflammation, differentiation, secretion of matrix vesicles and calcification in the cell and animal models respectively.Through this study project, we hope to confirm that aldosterone can induce CKD related vascular calcification via inflammatory signaling pathway of AIF-1, provide a new theoretical basis for prevention of vascular calcification.

目前已经证实醛固酮受体拮抗剂能抑制CKD相关血管钙化,但是由于其高钾血症的副作用使其在CKD患者中应用受到严格限制,积极探讨醛固酮诱导血管钙化的确切机制具有重要意义。申请者在研究醛固酮/AIF-1与肾间质纤维化关系时发现,醛固酮主要通过AIF-1依赖途径发挥效应。同时基于醛固酮在血管钙化中的作用,以及在AIF-1转基因小鼠体内发现AIF-1表达与血管钙化相关,申请者提出醛固酮也可能通过AIF-1参与血管钙化,但尚无相关文献报道。因此申请者提出醛固酮通过AIF-1信号诱导血管钙化,拟通过体内和体外实验探讨醛固酮激活AIF-1/NF-κB和AIF-1/mTORC1信号诱导单核巨噬细胞,血管内皮和平滑肌细胞相互作用,诱发平滑肌细胞炎症、分化、形成和分泌基质小泡,钙化的机制。本项目将首次证实醛固酮以AIF-1依赖方式激活CKD相关血管钙化的信号网络,为防治血管钙化提供新的理论依据和潜在治疗靶点。

项目摘要

目前已经证实醛固酮受体拮抗剂能抑制CKD相关血管钙化,但是由于其高钾血症的副作用使其在CKD患者中应用受到严格限制,积极探讨醛固酮诱导血管钙化的确切机制具有重要意义。申请者在研究醛固酮/AIF-1与肾间质纤维化关系时发现,醛固酮主要通过AIF-1依赖途径发挥效应。同时基于醛固酮在血管钙化中的作用,以及在AIF-1转基因小鼠体内发现AIF-1表达与血管钙化相关,申请者提出醛固酮也可能通过AIF-1参与血管钙化,但尚无相关文献报道。因此申请者提出醛固酮通过AIF-1信号通路诱导血管钙化,拟通过体内和体外实验探讨醛固酮激活AIF-1/PI3K/AKT/NF-κB、AIF-1/NF-κB/MCP-1/CCR-2和AIF-1/mTOR信号通路诱导单核巨噬细胞,血管内皮和平滑肌细胞相互作用,诱发平滑肌细胞炎症、钙化的机制。本项目将首次证实醛固酮以AIF-1依赖方式激活CKD相关血管钙化的信号网络,为防治血管钙化提供新的理论依据和潜在治疗靶点。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
2

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
3

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
4

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

DOI:
发表时间:
5

Sparse Coding Algorithm with Negentropy and Weighted ℓ1-Norm for Signal Reconstruction

Sparse Coding Algorithm with Negentropy and Weighted ℓ1-Norm for Signal Reconstruction

DOI:10.3390/e19110599
发表时间:2017

相似国自然基金

1

MicroRNA-30b通过调节自噬参与慢性肾脏病血管钙化的机制研究

批准号:81770766
批准年份:2017
负责人:姚丽
学科分类:H0511
资助金额:52.00
项目类别:面上项目
2

EZH2/Sox9在慢性肾脏病血管钙化中的作用和机制研究

批准号:81873617
批准年份:2018
负责人:叶朝阳
学科分类:H0505
资助金额:53.00
项目类别:面上项目
3

醛固酮通过抑制血管平滑肌细胞自噬促进血管钙化的机制

批准号:81870315
批准年份:2018
负责人:刘品明
学科分类:H0213
资助金额:57.00
项目类别:面上项目
4

慢性肾衰竭时炎症对血管平滑肌细胞钙化调节机制的研究

批准号:30370653
批准年份:2003
负责人:钱家麒
学科分类:H0505
资助金额:23.00
项目类别:面上项目